Coronavirus Drug Ingredients

India has banned export of anti-viral drug Remdesivir amid a surge in Covid cases in the country. In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients till situation stabilises

India will allow limited exports of the anti-malaria drug hydroxychloroquine, which is being tested as a coronavirus cure, to "nations that have been badly affected" by the pandemic, the government said today. Hours before the announcement, US President Donald Trump had made stunning comments about "retaliation" if India declined to ship the medici...

The government on Thursday asserted there is no shortage of raw ingredients or medicines in the country for next three months and a group of ministers is monitoring the situation on a daily basis to ensure preparedness for the challenge posed by the coronavirus outbreak.

US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.

Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.

An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

India has banned export of anti-viral drug Remdesivir amid a surge in Covid cases in the country. In an order, the government said it has banned export of Remdesivir injection and Remdesivir active pharmaceutical ingredients till situation stabilises

India will allow limited exports of the anti-malaria drug hydroxychloroquine, which is being tested as a coronavirus cure, to "nations that have been badly affected" by the pandemic, the government said today. Hours before the announcement, US President Donald Trump had made stunning comments about "retaliation" if India declined to ship the medici...

The government on Thursday asserted there is no shortage of raw ingredients or medicines in the country for next three months and a group of ministers is monitoring the situation on a daily basis to ensure preparedness for the challenge posed by the coronavirus outbreak.

US health regulators are watching for potential drug shortages after India restricted the export of some raw pharmaceutical ingredients, a move that could disrupt the industry's globe-spanning supply chain.

Indian pharma companies get almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.

An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.